PROSTATE CANCER
Attendees at a meeting of the American Association for Cancer Research learned that while the results of a study conducted at Rutgers University in New Brunswick, NJ, showed that atorva statin (Lipitor) and celecoxib (Celebrex) individually slowed tumor progression from androgen-dependent to androgen-independent status, the two drugs combined had additive growth-inhibiting activity compared with either drug alone.
According to a report from the American Cancer Society, 12 million new cases of malignancy were diagnosed worldwide in 2007; this translates to 7.6 million people dying from the disease.
Key Myeloma Mechanism Discovered In a discovery that might lead to a greater understanding of how multiple myeloma starts and how to best treat the disease, researchers from the National Cancer Institute (NCI) have identified changes to molecules in cancer cells that activate the NF-kappaB signaling pathway, which has an important role in cancer cell growth and survival.
ABSTRACT: In the United States, breast cancer and prostate cancer are the most common types of cancer diagnosed in women and men, respectively.
Childhood Cancer Survivors Have Higher Health Risks as Adults While more effective treatments for childhood cancers have dramatically improved survival rates, children who had been treated for cancer could to be at a higher risk of health problems as adults.
ABSTRACT: Therapeutic cancer vaccines differ from traditional vaccines in that they are only given to patients who already have cancer, with the goal of decreasing the spread of the disease and prolonging survival.
Prostate cancer is the most common solid tumor affecting men in the United States.
Breast Cancer Patients May Benefit from Second Opinion